arrow
H

Harish Seethapathy

University of California System
H指数:21
被引数:1,670

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparative safety of sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors in patients receiving anti-neoplastic therapies for cancer: an inverse probability treatment weighting analysis

钠-葡萄糖共转运蛋白-2抑制剂和二肽基肽酶-4抑制剂在癌症接受抗肿瘤治疗患者中的比较安全性:一项逆概率治疗加权分析

2025-07-280
PRE
F18-FDG PET imaging as a diagnostic tool for immune checkpoint inhibitor-associated acute kidney injury

F18-FDG PET成像作为免疫检查点抑制剂相关急性肾损伤的诊断工具

2024-08-080
OAAI
Sarcopenia, adiposity and large discordance between cystatin C and creatinine-based estimated glomerular filtration rate in patients with cancer
2024-04-222
OA
Immune-related adverse events and kidney function decline in patients with genitourinary cancers treated with immune checkpoint inhibitors
2021-11-0112
PRE